Salvage gemcitabine-vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy

Oral Oncology

Volumn 48, Issue 11, 2012, Pages 1146-1151

  Chen, Cui ^a   Wang, Feng Hua ^a   Wang, Zhi Qiang ^a   An, Xin ^a   Luo, Hui Yan ^a   Zhang, Le ^a   Chen, Yong Chang ^a   Xu, Rui Hua ^a   Li, Yu Hong ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Gemcitabine; Nasopharyngeal carcinoma; Platinum based chemotherapy; Salvage chemotherapy; Vinorelbine

Indexed keywords

CETUXIMAB; CISPLATIN; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; NAVELBINE; NEDAPLATIN; NIMOTUZUMAB; PACLITAXEL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HUMAN; INJECTION SITE PHLEBITIS; LEUKOPENIA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; SALVAGE THERAPY; SIDE EFFECT; THROMBOCYTOPENIA; UNIVARIATE ANALYSIS;

ADULT; AGE FACTORS; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; SALVAGE THERAPY; TREATMENT OUTCOME; VINBLASTINE;

EID: 84867881403     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.05.021     Document Type: Article

References (38)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2 2005 74 108
2. M. Al-Sarraf, M. LeBlanc, P.G. Giri, K.K. Fu, J. Cooper, and T. Vuong Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 J Clin Oncol 16 4 1998 1310 1317
3. J. Wee, E.H. Tan, B.C. Tai, H.B. Wong, S.S. Leong, and T. Tan Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety J Clin Oncol 23 27 2005 6730 6738
4. N. Lee, P. Xia, J.M. Quivey, K. Sultanem, I. Poon, and C. Akazawa Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Int J Radiat Oncol Biol Phys 53 1 2002 12 22
5. E.P. Hui, S.F. Leung, J.S. Au, B. Zee, S. Tung, and D. Chua Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group Cancer 101 2 2004 300 306
6. A.W. Lee, W.M. Sze, J.S. Au, S.F. Leung, T.W. Leung, and D.T. Chua Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience Int J Radiat Oncol Biol Phys 61 4 2005 1107 1116
7. A. Fandi, M. Bachouchi, N. Azli, A. Taamma, H. Boussen, and P. Wibault Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type J Clin Oncol 18 6 2000 1324 1330
8. P.M. Teo, W.H. Kwan, W.Y. Lee, S.F. Leung, and P.J. Johnson Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma Cancer 77 12 1996 2423 2431
9. M.E. Stein, P. Ruff, A. Weaving, J. Fried, and W.R. Bezwoda A phase II study of cisplatin/ifosfamide in recurrent/metastatic undifferentiated nasopharyngeal carcinoma among young blacks in southern Africa Am J Clin Oncol 19 4 1996 386 388
10. W. Yeo, T.W. Leung, A.T. Chan, S.K. Chiu, P. Yu, and T.S. Mok A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma Eur J Cancer 34 13 1998 2027 2031
11. D.T. Chua, J.S. Sham, and G.K. Au A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma Oral Oncol 41 6 2005 589 595
12. K.H. Chi, W.K. Chan, D.L. Cooper, S.H. Yen, C.Z. Lin, and K.Y. Chen A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma Cancer 73 2 1994 247 252
13. E. Au, and P.T. Ang A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma Ann Oncol 5 1 1994 87 89
14. J.S. McCarthy, I.F. Tannock, P. Degendorfer, T. Panzarella, M. Furlan, and L.L. Siu A phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma Oral Oncol 38 7 2002 686 690
15. T.L. Wang, and Y.O. Tan Cisplatin and 5-fluorouracil continuous infusion for metastatic nasopharyngeal carcinoma Ann Acad Med Singapore 20 5 1991 601 603
16. R.K. Ngan, H.H. Yiu, W.H. Lau, S. Yau, F.Y. Cheung, and T.M. Chan Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study Ann Oncol 13 8 2002 1252 1258
17. B.B. Ma, E.P. Hui, S.C. Wong, S.Y. Tung, K.K. Yuen, and A. King Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma-correlation with excision repair cross-complementing-1 polymorphisms Ann Oncol 20 11 2009 1854 1859
18. T.E. Ciuleanu, G. Fountzilas, E. Ciuleanu, M. Plataniotis, N. Todor, and N. Ghilezan Paclitaxel and carboplatin in relapsed or metastatic nasopharyngeal carcinoma: a multicenter phase II study J BUON 9 2 2004 161 165
19. Y.H. Li, F.H. Wang, W.Q. Jiang, X.J. Xiang, Y.M. Deng, and G.Q. Hu Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma Cancer Chemother Pharmacol 62 3 2008 539 544
20. W. Yeo, T.W. Leung, S.F. Leung, P.M. Teo, A.T. Chan, and W.Y. Lee Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma Cancer Chemother Pharmacol 38 5 1996 466 470
21. E.H. Tan, K.S. Khoo, J. Wee, K.W. Fong, K.S. Lee, and K.M. Lee Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma Ann Oncol 10 2 1999 235 237
22. H.Q. Huang, Z.M. Zhou, Y.H. Li, W.Q. Jiang, Y.J. He, and X.Y. Teng Preliminary results of ifosfamide and doxorubicin regimen in treatment of patients with recurrent and metastatic nasopharyngeal carcinoma Ai Zheng 21 4 2002 409 411
23. D.T. Chua, D.L. Kwong, J.S. Sham, G.K. Au, and D. Choy A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy Eur J Cancer 36 6 2000 736 741
24. B.B. Ma, I.F. Tannock, G.R. Pond, M.R. Edmonds, and L.L. Siu Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma Cancer 95 12 2002 2516 2523
25. J. Ngeow, W.T. Lim, S.S. Leong, M.K. Ang, C.K. Toh, and F. Gao Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma Ann Oncol 22 3 2011 718 722
26. K.F. Foo, E.H. Tan, S.S. Leong, J.T. Wee, T. Tan, and K.W. Fong Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type Ann Oncol 13 1 2002 150 156
27. L. Zhang, Y. Zhang, P.Y. Huang, F. Xu, P.J. Peng, and Z.Z. Guan Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy Cancer Chemother Pharmacol 61 1 2008 33 38
28. C.C. Wang, J.Y. Chang, T.W. Liu, C.Y. Lin, Y.C. Yu, and R.L. Hong Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma Head Neck 28 1 2006 74 80
29. K. Altundag, S. Aksoy, I. Gullu, O. Altundag, E. Ozyar, and S. Yalcin Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy Med Oncol 21 3 2004 211 215
30. V. Gebbia, A. Testa, R. Valenza, G. Zerillo, S. Restivo, and F. Ingria A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck Eur J Cancer 29A 9 1993 1358 1359
31. P. Dileo, J.A. Morgan, D. Zahrieh, J. Desai, J.M. Salesi, and D.C. Harmon Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trial Cancer 109 9 2007 1863 1869
32. J.H. Chen, P.Y. Chang, and N.S. Yao Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in advanced Hodgkin lymphoma Hematol Oncol Stem Cell Ther 2 2 2009 371 372
33. J.H. Chen, P.Y. Chang, and N.S. Yao Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in cisplatin-refractory germ cell tumor South Med J 102 5 2009 546 548
34. G. Frasci, V. Lorusso, N. Panza, P. Comella, G. Nicolella, and A. Bianco Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer J Clin Oncol 18 13 2000 2529 2536
35. G.P. Stathopoulos, S.K. Rigatos, N. Pergantas, D. Tsavdarides, I. Athanasiadis, and N.A. Malamos Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer J Clin Oncol 20 1 2002 37 41
36. P. Therasse, S.G. Arbuck, E.A. Eisenhauer, J. Wanders, R.S. Kaplan, and L. Rubinstein New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 3 2000 205 216
37. R.S. Herbst, C. Lynch, M. Vasconcelles, B.A. Teicher, G. Strauss, and A. Elias Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial Cancer Chemother Pharmacol 48 2 2001 151 159
38. M.H. Tay, Y.K. Ong, and K.F. Foo The role of salvage chemotherapy in metastatic nasopharyngeal carcinoma (NPC) Proc Am Soc Clin Oncol 2001 20 [abstract 2547]